Cargando…
Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms
Parkinson’s disease (PD) is a neurodegenerative disorder with motor deficits due to nigrostriatal dopamine depletion and with the non-motor/premotor symptoms (NMS) such as anxiety, cognitive dysfunction, depression, hyposmia, and sleep disorders. NMS is presented in at least one-fifth of the patient...
Autores principales: | Sun, Jinmei, Zhang, Wei, Wei, Zheng Zachory, Song, Xiaopeng, Jian, Liu, Jiang, Feng, Wang, Shuanglin, Li, Haibo, Zhang, Yongbo, Tuo, Houzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571301/ https://www.ncbi.nlm.nih.gov/pubmed/37833807 http://dx.doi.org/10.1186/s41016-023-00338-z |
Ejemplares similares
-
Before the Tremor: Premotor Symptoms of Parkinson’s Disease
por: Konkel, Lindsey
Publicado: (2013) -
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
por: Chen, Honglei, et al.
Publicado: (2013) -
Recent advances of biomaterials in biotherapy
por: Li, Ling, et al.
Publicado: (2016) -
Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study
por: Wu, Yu-Hsuan, et al.
Publicado: (2016) -
Biotherapies in Uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2020)